真实世界肺癌CT筛查表现、吸烟行为与对推荐意见的依从性:Lung-RADS分类与吸烟状态可预测依从性
该回顾性研究纳入2014至2019年至少接受两次低剂量CT肺癌筛查的260人,评估真实世界筛查表现及依从性预测因素。结果显示筛查敏感度100.0%、特异度84.8%、阳性预测值9.3%、阴性预测值100%,总体依从率43.0%且随Lung-RADS分类升高而递增;既往吸烟者和Lung-RADS≥3类是依从性的独立预测因素。
要点
- Lung-RADS分类越高依从性越高,Lung-RADS 1类33.2%至4X类100%(p<.001)。
- 既往吸烟者依从率50.0%高于当前吸烟者36.2%(p<.001)。
- 阴性筛查(Lung-RADS 1或2类)及当前吸烟者依从率均低于50.0%。
核心结论
- 真实世界肺癌筛查项目敏感度和阴性预测值很高,但特异度中等、阳性预测值很低;既往吸烟者及Lung-RADS 3类及以上者的依从性更高。
研究设计与样本
- 回顾性研究,纳入2014至2019年至少接受两次低剂量CT肺癌筛查的260人,记录人口学、吸烟史与行为变化、Lung-RADS分类、阳性预测值、阴性预测值和依从性,采用单因素比较和多因素logistic回归评估依从性预测因素。
关键影像表现/征象
- 260人中43人(16.5%)为阳性(Lung-RADS 3类及以上),其中3类27人(10.3%)、4A类8人(3.1%)、4B类6人(2.3%)、4X类2人(0.8%)。
- 260人中诊断癌症4人,其中肺癌3人、转移性黑色素瘤1人。
- 260人中基线当前吸烟者143人(55.0%),末轮筛查时当前吸烟者121人(46.5%)。
诊断标准与关键数值
- 低剂量CT肺癌筛查敏感度100.0%、特异度84.8%、阳性预测值9.3%、阴性预测值100%。
- 总体依从率43.0%,随Lung-RADS分类升高而递增:1类33.2%、2类46.3%、3类53.8%、4A类77.8%、4B类83.3%、4X类100%(p<.001)。
- 既往吸烟者依从率50.0% vs 当前吸烟者36.2%(p<.001)。
- 既往吸烟者和结节为Lung-RADS 3类及以上是依从性的仅有的显著独立预测因素。
临床应用与阅片要点
- 报告低剂量CT筛查结果时按Lung-RADS分类标注,便于识别依从性较低的人群。
- 对阴性筛查(Lung-RADS 1或2类)者及当前吸烟者,可关注其随访依从性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. Low-dose CT (LDCT) lung cancer screening (LCS) has been shown to decrease mortality in persons with a significant smoking history. However, adherence in real-world LCS programs is significantly lower than in randomized controlled trials. OBJECTIVE. The purpose of this article is to assess real-world LDCT LCS performance and factors predictive of adherence to LCS recommendations. METHODS. We retrospectively identified all persons who underwent at least two LCS examinations from 2014 to 2019. Patient demographics, smoking history and behavior changes, Lung-RADS category, PPV, NPV, and adherence to screening recommendations were recorded. Predictors of adherence were assessed via univariate comparisons and multivariate logistic regression. RESULTS. A total of 260 persons returned for follow-up LDCT (57.7% had two, 34.2% had three, 7.7% had four, and 0.4% had five LDCT examinations). A total of 43 of 260 (16.5%) had positive (Lung-RADS category 3 or above) scans, of which 27 of 260 persons (10.3%) were graded as Lung-RADS category 3, eight of 260 (3.1%) were category 4A, six of 260 (2.3%) were category 4B, and two of 260 (0.8%) were category 4X. Cancer was diagnosed in four of the 260 (three with lung cancer and one with metastatic melanoma). A total of 143 of 260 (55.0%) persons were current smokers at baseline and 121 of 260 (46.5%) were current smokers at the last round of LCS. LCS had sensitivity of 100.0%, specificity of 84.8%, PPV of 9.3%, and NPV of 100%. Overall adherence was 43.0% but increased progressively with higher Lung-RADS category (Lung-RADS 1: 33.2%; Lung-RADS 2: 46.3%; Lung-RADS 3: 53.8%; Lung-RADS 4A: 77.8%; Lung-RADS 4B: 83.3%; Lung-RADS 4X: 100%; p < .001). was also higher in former versus current smokers (50.0% vs 36.2%; p < .001). Being a former smoker and having a nodule that is Lung-RADS category 3 or greater were the only significant independent predictors of adherence. CONCLUSION. Our real-world LCS program showed very high sensitivity and NPV, but moderate specificity and very low PPV. Adherence to LCS recommendations increased with former versus current smokers and in those with positive (Lung-RADS categories 3, 4A, 4B, or 4X) LCS examinations. Adherence was less than 50.0% in current smokers and persons with negative (Lung-RADS categories 1 or 2) LCS examinations. CLINICAL IMPACT. Our results offer a road map for targeted performance improvement by focusing on LCS subjects less likely to remain in the program, such as persons with negative LCS examinations and persons who continue to smoke, potentially improving LCS cost effectiveness and maximizing its societal benefits.
引用
- Barbosa EJM, Yang R, Hershman M, et al. Real-World Lung Cancer CT Screening Performance, Smoking Behavior, and Adherence to Recommendations: Lung-RADS Category and Smoking Status Predict Adherence. AJR Am J Roentgenol. 2021. PMID: 32755178. doi:10.2214/AJR.20.23637
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。